About the Journal

 

LabAnimal is a journal dedicated to in vivo science and technology that improves our basic understanding and use of model organisms of human health and disease. In addition to basic research, methods and technologies, LabAnimal also covers important news, business and regulatory matters that impact the development and application of model organisms for preclinical research.

LabAnimal’s focus is on innovative in vivo methods, research and technology covering a wide range of model organisms. Our broad scope ensures that the work we publish reaches the widest possible audience. LabAnimal provides a rigorous and fair peer review of manuscripts, high standards for copyediting and production, and efficient publication.

LabAnimal publishes a range of content types covering primary research articles, reviews and perspectives. All editorial decisions at LabAnimal are made by a dedicated team of full-time professional editors. For more information on the editors’ research backgrounds and scientific interests.

About the Editors

Chief Editor: Alexandra Le Bras

Alexandra did her PhD at the Institute of Biology in Lille, France, where she studied the transcriptional and epigenetic mechanisms regulating endothelial gene expression. She then conducted postdoctoral research, investigating vascular development in stem cell and mouse models (Harvard Medical School, USA) and working on gene and cell therapy approaches for cardiovascular disease (King’s College London, UK). Before joining LabAnimal in February 2019, she was Locum Associate Editor at Nature Reviews Cardiology for a year. alexandra.lebras@nature.com

Senior Editor: Ellen Neff

Ellen joined LabAnimal in the summer of 2016. Before starting in editorial, she was a coordinator for a NASA Earth Science metadata project, focused on facilitating accessible research that is comprehensible to a broad audience. She studied biology with minors in chemistry and classics at the University of Pittsburgh and completed her graduate degree in marine biology at Northeastern University. Although her invertebrate subjects were outside the purview of IACUCs, she has experience in whole organism biology and the science of indirect effects and interactions. 

Editorial Advisory Panel

In addition to our editorial team, LabAnimal has an editorial advisory panel with experts from academia and industry in fields covering in vivo science & technology.

 

  • Leanne Alworth, DVM, MS, DACLAM – Assistant Director/Attending Veterinarian, University of Georgia, Athens, GA
  • Jeffrey Everitt, DVM – Department of Pathology, Duke University, Durham, NC
  • Charmaine Foltz, DVM, DACLAM – Director, Division of Veterinary Resources, NIH, Bethesda, MD
  • Paul Houghton – CEO, Biologist, Primate Products, Redwood City, CA
  • Robert F. Hoyt, Jr., DVM, MS, DACLAM – Animal Program Director, Frederick National Laboratory for Cancer Research, National Cancer Institute, Bethesda, MD
  • Mary Lou James, BA, RLATG –Consultant, Regulatory Compliance, St. Louis, MO
  • Bruce W. Kennedy, MS, RLATG, CMAR, CPIA – IACUC Administrator, Office of Research, Chapman University, Orange, CA
  • Krishnan Kolappaswamy, DVM, PhD, DACLAM –Head, Laboratory Animal Science, Safety Pharmacology & Animal Research Center, Translational Safety & Bioanalytical Sciences, Amgen, Thousand Oaks, CA
  • Richard H. Latt, DVM, DACLAM –President, Mispro Biotech Services Inc., Montreal, Quebec, Canada
  • John A. Maher, MS, MBA, CMAR, RLATG – Associate Director, Comparative Medicine, Pfizer, Pearl River, NY
  • Jörg Mayer, Dr.med.vet., MSc, MRCVS, DABVP (ECM) – Associate Professor of Zoological Medicine, College of Veterinary Medicine, University of Georgia, Athens, GA
  • Jo Ellen Sherow, BS, LATG – Director, Research Compliance, Ohio University, Athens, OH
  • Michael K. Stoskopf, DVM, PhD, DACZM – Professor and Director of Environmental Medicine Consortium, College of Veterinary Medicine, North Carolina State University, Raleigh, NC
  • Robert H. Weichbrod, PhD, MBA, RLATG – Animal Program Administrator, National Eye Institute, NIH, Bethesda, MD
  • Axel Wolff, MS, DVM – Director, Division of Compliance Oversight, OLAW, NIH, Bethesda, MD